Chad J. Kolean
2023
In 2023, Chad J. Kolean earned a total compensation of $1.1M as Chief Financial Officer at Cellectar Biosciences, a 140% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $234,000 |
|---|---|
| Option Awards | $284,960 |
| Salary | $390,000 |
| Stock Awards | $112,770 |
| Other | $87,230 |
| Total | $1,108,960 |
Kolean received $390K in salary, accounting for 35% of the total pay in 2023.
Kolean also received $234K in non-equity incentive plan, $285K in option awards, $112.8K in stock awards and $87.2K in other compensation.
Rankings
In 2023, Chad J. Kolean's compensation ranked 1,103rd out of 3,006 executives tracked by ExecPay. In other words, Kolean earned more than 63.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,103 out of 3,006 | 63rd |
Division Manufacturing | 656 out of 1,650 | 60th |
Major group Chemicals And Allied Products | 449 out of 918 | 51st |
Industry group Drugs | 438 out of 881 | 50th |
Industry Pharmaceutical Preparations | 300 out of 637 | 53rd |
Source: SEC filing on April 26, 2024.
Kolean's colleagues
We found two more compensation records of executives who worked with Chad J. Kolean at Cellectar Biosciences in 2023.